Dendritic polyglycerolsulfate-SS-poly(ester amide) micelles for the systemic delivery of docetaxel: pushing the limits of stability through the insertion of π-π interactions
- PMID: 37006120
- DOI: 10.1039/d3tb00055a
Dendritic polyglycerolsulfate-SS-poly(ester amide) micelles for the systemic delivery of docetaxel: pushing the limits of stability through the insertion of π-π interactions
Abstract
Insufficient stability of micellar drug delivery systems is still the major limitation to their systematic application in chemotherapy. This work demonstrates novel π-electron stabilized polyelectrolyte block copolymer micelles based on dendritic polyglycerolsulfate-cystamine-block-poly(4-benzoyl-1,4-oxazepan-7-one)-pyrene (dPGS-SS-POxPPh-Py) presenting a very low critical micelle concentration (CMC) of 0.3 mg L-1 (18 nM), 55-fold lower than that of conventional amphiphilic block copolymer micelles. The drug loading capacities of up to 13 wt% allow the efficient encapsulation of the chemotherapeutic Docetaxel (DTX). The spherical morphology of the micelles was proven by cryogenic electron microscopy (cryo-EM). Gaussian Analysis revealed well-defined sizes of 57 nm and 80 nm in the unloaded/loaded state, respectively. Experiments by dynamic light scattering (DLS), ultraviolet-visible spectroscopy (UV-VIS), fluorescence spectroscopy, and cross-polarization solid-state 13C NMR studied the π-π interactions between the core-forming block segment of dPGS-SS-POxPPh-Py and DTX. The findings point to a substantial contribution of these noncovalent interactions to the system's high stability. By confocal laser scanning microscopy (CLSM), the cellular uptake of fluorescein-labelled FITC-dPGS-SS-POxPPh-Py micelles was monitored after one day displaying the successful cell insertion of the cargo-loaded systems. To ensure the drug release in cancerous cells, the disassembly of the micellar DTX-formulations was achieved by reductive and enzymatic degradation studied by light scattering and GPC experiments. Further, no size increase nor disassembly in the presence of human serum proteins after four days was detected. The precise in vitro drug release was also given by the high potency of inhibiting cancer cell growth, finding half-maximal inhibitory concentrations (IC50) efficiently reduced to 68 nM coming along with high viabilities of the empty polymer materials tested on tumor-derived HeLa, A549, and McF-7 cell lines after two days. This study highlights the substantial potential of micelles tailored through the combination of π-electron stabilization with dendritic polyglycerolsulfate for targeted drug delivery systems, enabling them to have a significant foothold in the clinical treatment of cancer.
Similar articles
-
Synthesis, in vitro characterization, and anti-tumor effects of novel polystyrene-poly(amide-ether-ester-imide) co-polymeric micelles for delivery of docetaxel in breast cancer in Balb/C mice.Drug Dev Ind Pharm. 2018 Jul;44(7):1139-1157. doi: 10.1080/03639045.2018.1438462. Epub 2018 Feb 21. Drug Dev Ind Pharm. 2018. PMID: 29436875
-
Redox-sensitive micelles assembled from amphiphilic mPEG-PCL-SS-DTX conjugates for the delivery of docetaxel.Colloids Surf B Biointerfaces. 2016 Jun 1;142:89-97. doi: 10.1016/j.colsurfb.2016.02.045. Epub 2016 Feb 23. Colloids Surf B Biointerfaces. 2016. PMID: 26938324
-
Disulfide-Linked Amphiphilic Polymer-Docetaxel Conjugates Assembled Redox-Sensitive Micelles for Efficient Antitumor Drug Delivery.Biomacromolecules. 2016 May 9;17(5):1621-32. doi: 10.1021/acs.biomac.5b01758. Epub 2016 Apr 5. Biomacromolecules. 2016. PMID: 27018501
-
Toolbox of Biodegradable Dendritic (Poly glycerol sulfate)-SS-poly(ester) Micelles for Cancer Treatment: Stability, Drug Release, and Tumor Targeting.Biomacromolecules. 2021 Jun 14;22(6):2625-2640. doi: 10.1021/acs.biomac.1c00333. Epub 2021 Jun 2. Biomacromolecules. 2021. PMID: 34076415
-
Targeted delivery of docetaxel via Pi-Pi stacking stabilized dendritic polymeric micelles for enhanced therapy of liver cancer.Mater Sci Eng C Mater Biol Appl. 2017 Jun 1;75:1042-1048. doi: 10.1016/j.msec.2017.02.098. Epub 2017 Feb 24. Mater Sci Eng C Mater Biol Appl. 2017. PMID: 28415388
Cited by
-
Exploring the potential of silymarin-loaded nanovesicles as an effective drug delivery system for cancer therapy: in vivo, in vitro, and in silico experiments.Naunyn Schmiedebergs Arch Pharmacol. 2024 Sep;397(9):7017-7036. doi: 10.1007/s00210-024-03099-3. Epub 2024 Apr 17. Naunyn Schmiedebergs Arch Pharmacol. 2024. PMID: 38630254
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous